On 15th July the Royal Brompton & Harefield NHS Foundation Trust held its 6th annual heart and lung research open day, attracting over 100 visitors.
Held at Royal Brompton Hospital, the open day celebrated the 10th anniversary of the National Institute for Health Research (NIHR), the research arm of the NHS which helps fund the Trust’s research.
Visitors included members of the public from local schools, colleges and universities, as well as researchers and academics from Imperial College London.
The day gave visitors the able to see some of the groundbreaking research carried out at the hospital during this fun and informative day.
Lucky members of the public tried their hand at navigating a simulated heart to fix a heart rhythm, found out what 3D printing tells us about lungs, looked at hearts from different animals, and explored the role genes play in heart and lung health while extracting DNA from strawberries.
Some also learned about the latest heart and lung research taking place at the Trust through 16 interactive demonstrations and by talking to clinical researchers and scientists. There was also a round-table talks with experts and discussions on the role that stem cells and artificial intelligence may play in heart health.
Visitors also found out about the research studies that hundreds of patients and healthy volunteers participate in each year at Royal Brompton & Harefield NHS Foundation Trust, with its university partner, Imperial College London, and see how this research leads to significant medical breakthroughs and the development of new treatments.
David Lillicrap, a patient who attended the event, said: “I thought that the subjects spanned were excellent and opened my eyes to the breadth of research that goes on at Royal Brompton Hospital.”
Funding for the event was provided by both the NIHR Royal Brompton Respiratory and Cardiovascular Biomedical Research Units (BRUs).
Julia Coffey, public involvement coordinator in the Cardiovascular BRU, said: “Research underpins a great deal of clinical work at the Trust, and one of our guiding organisational values reflects a commitment to finding and developing new treatments for heart and lung disease, for today’s patients and for future generations.”